Bracket Patient Engagement and eCOA Innovator Jeff Lee Named to PharmaVOICE 100 Most Inspirational People 2018

Founder of mProve Health passionate about improving the patient experience in clinical trials using modern mobile technologies

King of Prussia, PA – Bracket, a technology company providing solutions for better patient outcomes and actionable insights, is honored to announce patient-centric innovator Jeff Lee has been named one of the PharmaVOICE 100 most inspirational people in the life sciences industry. As President, eCOA, Patient Engagement at Bracket, Lee is dedicated to building solutions that deliver an outstanding user experience, transforming the way patients participate in clinical research.

For more than a dozen years, PharmaVOICE magazine has recognized the most inspirational, motivational, and transformational individuals throughout the life-sciences industry in its annual July/August PharmaVOICE 100 issue. As always, this year’s distinguished honorees were nominated by thousands of PharmaVOICE readers and were selected for inclusion based on how they inspire others, their positive impact on patients and the industry at large, their innovative thinking, their mentorship to the next generation of leaders, and their willingness to give their time and resources to their communities and philanthropic causes.

“I am humbled and honored to be recognized among such a worthy group of inspiring people by PharmaVOICE, especially because nominations come from clinical operations leaders who use and value our solutions,” said Lee. “It’s crucial to be able to put yourself in the mindset of the patient, the research site, the client, employees – or even business partners. This allows for insight and collaboration that many people just don’t unlock. Empathy is a secret weapon for success.”

Lee founded mProve Health in 2010 to improve the patient experience in clinical trials with a BYOD philosophy that makes it easy for patients to stay invested in the study. mProve quickly became a leading provider of patient engagement and eCOA solutions on mobile devices, and was acquired by Bracket in 2017.

“Jeff’s entrepreneurial spirit, visionary approach, and clinical trial expertise all in pursuit of bringing much-needed treatments to patients epitomize what it means to be a PharmaVOICE 100,” says Taren Grom, editor and co-founder, PharmaVOICE. “In addition, he is an inspirational leader who is lifting his teams to new heights in their pursuit to make a difference in the industry.”

Today, 18 of the top 20 pharmaceutical companies currently use Bracket technology solutions to manage their clinical trials. The company’s patient engagement solutions are designed to help study sponsors and CROs improve retention rates in clinical trials, increase compliance to study protocols, and ensure adherence to therapy.

Lee is listed amongst the commanders and chiefs in the PharmaVOICE 100 issue. Read his full profile here.

About Bracket:

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

 

 

 

Discuss and Determine the Future of eClinRO and Computerized Assessments for Alzheimer’s Disease Research with Bracket at AAIC 2018

Schedule a meeting with Bracket’s expert clinicians and data scientists at AAIC exhibit booth #607 to discover the latest technology for capturing and analyzing reliable clinical trial data

King of Prussia, PA – Attendees at the AAIC 2018 meeting, hosted by the Alzheimer’s Association, are invited to join Bracket to discuss and determine the future of eClinRO and computerized assessments in Alzheimer’s Disease research.

Schedule a meeting to begin a conversation with distinguished clinicians and expert data scientists including Amir Kalali, MD, David Miller, MD, Sarah Karas, PsyD, Todd Feaster, PsyD, Todd M. Solomon, PhD, and Pascal Goetghebeur.

Over the years, Bracket has built deep CNS expertise, including the development of specialized solutions for rater training and certification, quality assurance, and computerized assessments built with a focus on optimizing the patient experience. In particular, the Bracket Rater Station™ is a regulatory-compliant technology that has been used to deliver 45,000 unique scale administrations to over 5,000 patients in more than 60 languages. It is an advanced eClinRO tool that improves interview quality while reducing administration and scoring errors.

Get a demo to gain firsthand experience of Bracket technology, including Rater Station, at AAIC.

In addition to subject matter experts and technology solutions, Bracket will continue to contribute to the scientific discussion with papers and poster sessions at the conference:

  • “Analysis of the Rates and Types of Errors on Enhanced eCOA Versions of the Alzheimer’s Diseases Assessment Scale – Cognitive Subscale and Mini Mental State Examination Used in Clinical Trials of Dementia” presented by first author Solomon at location P1-068 on Sunday, July 22
  • “The Use of Statistical Modeling to Complement Data Quality Programs” presented by first author Karas at location P1-064 on Sunday, July 22
  • “Pilot Validation of an Electronic Alzheimer’s Disease Assessment Scale-Cognitive Subscale” presented by first author Solomon at location P2-035 on Monday, July 23
  • “Electronic ADAS-Cog (eADAS-Cog) Data Quality: How Do Countries Compare?” presented by first author Feaster at location P3-018 on Tuesday, July 24
  • White paper describing the importance of computerized cognitive assessments given new FDA guidance for early AD research by first author Goetghebeur available at Bracket exhibit booth #607

To learn more about Bracket and Alzheimer’s Disease research, begin a conversation at AAIC 2018.

About Bracket

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket

Combined organization will bring together complementary strengths with a shared focus on accelerated customer value through patient-centric clinical technology solutions

LONDON and WAYNE, Pa.July 17, 2018  — Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. As part of the transaction, CRF will be combined with Bracket, a provider of software and technology-enabled solutions utilized in clinical trials. Bracket is a portfolio company of Genstar.

CRF Health has been majority-owned by Vitruvian Partners, a leading growth-and technology-focused investment firm, since 2015.

The newly combined organization will drive accelerated value for pharmaceutical companies and CRO customers, providing patient-centric solutions, combined with deep and broad therapeutic area expertise, across a strong and efficient global footprint.

“CRF Health earned an outstanding reputation with 20 years of experience providing eCOA and now eConsent solutions to the biopharma industry around the world,” said Mike Nolte, who will lead the combined organization as CEO. “CRF’s technology and therapeutic experience dovetail well with our solutions, and they expand our ability to support increasingly complex clinical research. I am excited to bring two outstanding teams together to provide a reliable and scalable platform that accelerates the development of life changing medicines for our families and communities across the globe.”

The combined company will have over 1,500 employees worldwide, and will be in a position to accelerate the penetration of user-friendly technologies across the clinical trial spectrum – driving the transfer from manual, paper based services to electronic while improving service quality and data integrity.

“This is an exciting step forward for patients, clients, and our new combined team,” said Rachel Wyllie, CEO of CRF Health, who will become the Executive Chairman of the combined company. “The complementary nature of the two businesses provides us with the platform and scale for future growth in our dynamic markets, while ensuring our customers have more access to the latest patient-centric innovations in clinical research.”

Jean-Pierre Conte, Chairman and Managing Director at Genstar Capital, added, “Bringing CRF and Bracket together will create a world-class healthcare technology company supporting clinical trials and will accelerate adoption and growth in eCOA, eConsent, patient engagement, rater training and trial supply management solutions. We look forward to working with the outstanding leaders at both organizations. This notable event in pharmaceutical services is another example of Genstar’s private equity strategy of driving change at our portfolio companies to create high-growth and extremely valuable companies. Healthcare is an important sector for Genstar and we continue to identify great opportunities to apply our growth model to build great companies.”

Philip Russmeyer, Partner at Vitruvian Partners, commented, “We are delighted to support the combination of Bracket and CRF to further accelerate, and build upon, the excellent advances that our partnership with the strong management team at CRF has produced over the past years.”

The transaction is expected to be completed by the end of 2018 and is subject to customary closing and regulatory approvals.

Jefferies International Limited served as exclusive financial adviser and Dickson Minto as legal adviser to CRF.  Ropes & Gray LLP served as legal adviser to Genstar Capital.

About Bracket

Bracket (www.bracketglobal.com) is a technology company that accelerates clinical research and improves the experience of patients accessing potentially life-changing therapies. Our solutions, combined with deep scientific and clinical insight, link engaged patients to researchers, provide faster, more reliable decision making, and help provide longer, healthier and more productive lives for our families and communities around the globe. Bracket has over 800 employees and delivers services in more than 90 countries to a diverse base of global customers, including 15 of the top 20 biopharma companies.

About CRF Health

CRF Health is the leading provider of patient-centered eSource technology solutions for the life sciences industry. With experience in more than 800 clinical trials, over 100 languages and across 74 countries, CRF Health’s TrialMax® platform consistently demonstrates the industry’s highest data accuracy, patient and site compliance, and patient retention. The integrated TrialMax platform includes eCOA solutions for collecting PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes), ClinROs (Clinician or Rater Reported Outcomes), and PerfOs (Performance Outcomes), and features TrialConsent®, an electronic solution for collecting and managing informed consent in clinical trials. CRF Health’s eSource solutions improve trial engagement by making the patient the center of the clinical trial process.

About Genstar Capital

Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar manages funds with total capital commitments of approximately $10 billion and targets investments focussed on targeted segments of the healthcare, financial services, software, and industrial technology industries.

About Vitruvian Partners

Vitruvian is a European growth-focused investment firm specialised in ‘dynamic situations’, where companies undergo growth and change typically driven by technology. Vitruvian helps portfolio companies scale their operations by providing an operational support system and assistance with strategic initiatives including acquisitions. Other notable investments to date include global market leaders in their field such as Just Eat, FarFetch, Skyscanner, EasyPark, Snow Software, Trustpilot, Voxbone, Callcredit, Ebury and others. The €2.4bn Vitruvian Investment Partnership III (“VIP III”) is among the largest pools of capital in Europe supporting innovative and higher growth companies. Vitruvian has backed 30 companies in its first two funds and has assets under management of c. €5 billion, operating out of offices in LondonMunichStockholmLuxembourg and San Francisco. More information can be found at: www.vitruvianpartners.com

 

Bracket to Demonstrate Technology that Brings Pharmaceutical Companies Closer to their Patients at DIA Annual Meeting 2018

Visit booth #2522 to improve the patient experience, enable more reliable data capture in clinical trials, and watch (and play) plenty of soccer

King of Prussia, PA – Bracket, a technology company connecting patients to potentially life-changing therapies through faster and more reliable clinical research, will engage with clinical research leaders to showcase solutions that bring pharmaceutical companies closer to their patients at the DIA Annual Meeting in Boston, MA, from June 24-28, 2018.

Exhibit booth #2522 will be an active center for technology demonstrations and insightful conversations with sponsors and CROs determined to improve the patient experience and capture better, more reliable data worldwide.

Schedule a demo to experience the value of Bracket solutions firsthand.

  • Bracket eCOA: A mobile data collection solution that engages patients, caregivers, and clinical site staff. It can be used on provisioned or personal devices and includes robust services for scale management, data management, logistics, and outcomes advisory.
  • Bracket Patient Engagement: A mobile app and reminder system proven to boost patient compliance and study completion. It has been used by 18 of the top 20 pharmaceutical companies to engage research patients around the globe.
  • Bracket Neuroscience: An advanced solution for collecting clinician-rated endpoint data in neurology studies. Its advanced analytics and scientific services improve study data quality by maximizing rater reliability.
  • Bracket IRT & Clinical Supplies: An industry-trusted, quick-deploy solution for managing randomization and clinical supplies. It integrates seamlessly with Bracket SmartSupplies to forecast, label, distribute, manage and reconcile clinical supplies.

Visitors to the Bracket booth will also have the opportunity to share challenges and brainstorm best practices with subject matter experts including distinguished ePRO Consortium member Serge Bodart, Senior Adviser Outcomes Science, and Jeff Lee, President of eCOA and Patient Engagement, the patient technology innovator who founded mProve Health (acquired by Bracket in 2017).

In addition to technology discussions and live solution demonstrations, Bracket will help provide some well-deserved entertainment breaks with opportunities for casual fun:

  • Live viewings of global soccer tournament matches and a free-to-play foosball table
  • Daily raffles for an Amazon Echo Show
  • The “can’t miss” social event of the conference, Bracket’s annual party with CluePoints, this year to be held on Tuesday, June 26, at The Grand nightclub opening at 10pm. RSVP here then pick up your ticket at the Bracket booth.

“We are moving urgently to deliver new, high-impact capabilities for customers,” said Mike Nolte, Bracket CEO. “Inside Bracket, we’re adding even more expert talent to our team and investing in exciting new patient technology offerings built off years of established success. More importantly, we’re focused on connecting researchers and patients to accelerate the quality and speed of clinical trials through active engagement. Our industry has the noble responsibility to support longer and more productive lives for our families and communities around the world, and we are dedicated to supporting their success with great technology that patients love. I’m excited to share some of it with you at DIA.”

About Bracket

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

Bracket Appoints James Jay as Senior Vice President, Endpoint Solutions to Drive Continued Growth of Its Technology and Service Offerings

WAYNE, Pa., — June 5, 2018—Bracket, a leading clinical trial technology and specialty services provider, today announced James Jay has joined the Company as Senior Vice President, Endpoint Solutions, reporting to Bracket’s Chief Executive Officer, Mike Nolte. In this role, James will lead the Bracket business focused on eCOA, Rater Training, Analytics, Cognitive Testing, and Rater Quality technology solutions.

“James brings leadership, vision and creativity to Bracket’s growing team,” said Mike Nolte, CEO. “He will be essential in our ongoing efforts to build patient-centric, innovative technologies, advance our data and analytics strategy and support our pharmaceutical and biotechnology clients.”

James has 18 years of experience building successful software solutions for healthcare and life sciences. For the last six years he led the Global Imaging IT business at Agfa HealthCare, where he transformed the business strategy while creating a new market segment and established early market leadership. Prior to Agfa, James spent 13 years at GE, where he led the Global Cardiology IT business, and held other roles across R&D and program management.

James has an MBA in Global Management from American Intercontinental University and a BS in Computer Science from the University of Oregon.

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Media Contacts

Kristen Everett, Sagefrog, kristene@sagefrog.com

Kris Sarajian, Kristopher.Sarajian@bracketglobal.com

Bracket Appoints Mitch Blumenfeld as Chief Financial Officer

WAYNE, Pa., — May 22, 2018 – Bracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Mitch Blumenfeld as Chief Financial Officer.

Blumenfeld has extensive experience as a financial leader for life science and technology companies. He joins Bracket from PCI Pharma Services, the world’s largest provider of outsourced pharmaceutical packaging and related services where he was responsible for all financial management for 18 facilities across North America, Europe and Australia, led a successful exit to Partners Group and completed five acquisitions in four years.

“The opportunity to help a great business into their next phase of growth is a tremendous opportunity,” said Blumenfeld. “I’m looking forward to the chance to continue my personal investment in the clinical research industry and to support Bracket’s mission to improve the patient experience, while delivering speed and reliability in clinical trials.”

Prior to his time with PCI, Blumenfeld served in business leadership roles at a variety of clinical and technology businesses. From 2006 to 2013 Mitch worked for AmerisourceBergen as the Senior Vice President and CFO of the Drug Corporation and led the integration and finance functions for World Courier, the world leader in global cold chain and clinical trial logistics with offices in over 140 countries.

“Mitch is an outstanding and proven CFO, with a tremendous track record and deep experience transforming and growing great businesses,” said Mike Nolte, CEO at Bracket.  “I’m proud to have him on this team and I look forward to working together to lead Bracket’s future growth.”

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Media Contacts

Kristen Everett, Sagefrog Marketing Group, kristene@sagefrog.com

Adam Butler, Bracket, adam.butler@bracketglobal.com

Bracket Appoints Serge Bodart to Scientific Leadership as eCOA Subject-Matter Expert

May 01, 2018, Wayne, PABracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Serge Bodart, MS, as Senior Advisor, Outcomes Science, where he will build upon the existing breadth and depth of Bracket’s scientific and technical thought leadership while serving specifically as the Company’s electronic clinical outcomes assessments (eCOA) subject-matter expert.

Serge is a seasoned clinical trial technology executive who has been immersed in the eCOA and patient reported outcomes (ePRO) industry for more than 20 years. In addition to serving as a member of the ePRO Consortium for the past four years, Serge also Co-founded and served as Chief Executive Officer to Symfo, a European-based ePRO provider. With international entrepreneurial experience in the space, Serge brings an impressive level of functional and technical knowledge about eCOA to Bracket, understanding its lifecycle from concept to commercialization and its impacts on sites and patients.

“Joining Bracket’s scientific team in a leadership capacity is an exciting opportunity,” said Serge. “I look forward to not only improving how researchers engage with patients in clinical trials on a larger, global scale through Bracket’s advanced and comprehensive eCOA platform, but also helping to legitimize the use of technology in clinical trials as a whole by generating greater awareness with thought leadership.”

In his role as Senior Advisor, Outcomes Science, Serge will provide scientific oversight for all of Bracket’s ePRO activities, and will contribute to our research and new product development initiatives.

“We are pleased to welcome Serge to Bracket and further advance our flagship eCOA and ePRO product suite with his diverse perspectives, unparalleled enthusiasm and subject-matter expertise,” said Jeff Lee, President, mProve Health, a Bracket Company. “His impressive track record of transformational leadership will be a major asset to our rich pipeline of impending and long-term innovations to our eCOA and ePRO platforms, and to advancing the use and adoption of technology in clinical trials a whole.”

Prior to his eCOA career, Serge served as Major and helicopter pilot for more than 20 years in the Belgian Army Aviation. He is currently based in Montreal, Canada and holds a M.S. degree in Telecommunications from the Polytechnic Division of the Royal Military Academy in Brussels, Belgium.

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at www.bracketglobal.com.

Contact

Kristen Everett
Sagefrog Marketing Group on behalf of Bracket
kristene@sagefrog.com | 267-357-7018

Bracket’s ePRO Solution Wins CARE Award for Best Patient-Focused Technological Development

Bracket, a leading clinical trial technology and specialty services provider, has won the Best Patient-Focused Technological Development award at the Clinical and Research Excellence (CARE) Awards. The award, which acknowledges 2018’s best advancement in improving data collection and the patient experience, recognizes the success of Bracket’s ePRO and patient engagement solution in boosting study compliance and completion by making patients feel like partners in their clinical trial.

Commenting on the award, Bracket’s President, eCOA and Patient Engagement, Jeff Lee, said: “We are delighted that our solution has been recognized by the CARE Awards’ 2018 judging panel. Patients are the lifeblood of clinical trials and we set out with the goal of building a comprehensive ePRO solution that would make them feel like ‘partners’ in their clinical trial rather than merely a ‘data set’. Bracket’s mobile ePRO solution goes beyond delivering robust trial instruments—it leads with BYOD capabilities and includes patient engagement features alongside integrations to complementary third-party solutions, such as eConsent, payments and lab courier services to improve the patient experience.”

Bracket’s ePRO solution works on iPhone and Android operating systems for seamless use on provisioned or personal devices. In a single mobile touchpoint patients access validated survey instruments as well as everything they need to feel empowered and informed for the duration of the clinical trial, including: personalized reminders (via text-message or push notification), visit schedule information, the ability to confirm or cancel appointments, multimedia reference tools, gamification, direct-from-site communications, and third party study services. The mobile app makes it easy for patients to keep up with their study commitments and eliminates the need to use multiple, disparate technologies. In a recent clinical study, patients who used Bracket’s ePRO and engagement solution were more likely to comply with the study protocol, complete their diaries, and were up to 80% less likely to withdraw from the study.

The CARE Awards acknowledge and applaud the pharmaceutical sector’s outstanding performers across all areas of the industry, recognizing both corporate and individual achievements. To see the full list of 2018 CARE Awards winners please visit: https://pharmaintelligence.informa.com/events/awards/care-awards-2018

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

About Informa Pharma Intelligence

Informa Pharma Intelligence powers a full suite of analysis products – Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet and In Vivo – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.

With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com.

About Informa PLC

Informa operates at the heart of the Knowledge and Information Economy. It is one of the world’s leading business intelligence, academic publishing, knowledge and events businesses. With more than 6,500 employees globally, it has a presence in all major geographies, including North America, South America, Asia, Europe, the Middle East and Africa.

Bracket Appoints Michael Nolte as New CEO

WAYNE, Pa., — Bracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Michael P. Nolte as Chief Executive Officer. The company’s current CEO, Jeff Kinell, will remain on the Bracket Board of Directors as a strategic advisor.

Mike Nolte is a seasoned industry leader who joins Bracket after serving as the Chief Executive Officer of Influence Health, where he led the strategy and delivery for the Consumer Experience Platform, supporting consumer-centric, digital healthcare. With a career spent at the intersection of healthcare, technology and service delivery, Nolte’s breadth of experience, strategic insight and proven track record align well with Bracket’s goals as it continues to invest in science-based,  clinical development technology and service solutions.

“I am thrilled to join the Bracket team, and I look forward to this unique opportunity in an outstanding business at a unique and pivotal moment,” said Nolte, CEO of Bracket. “This is an exceptional chance to relentlessly pursue value for our customers, broaden our impact on clinical trials, and transform how clinical research is conducted by using technology and data to improve patient outcomes.”

Prior to Influence Health, Mike served as the President and COO of MedAssets and spent 7 years at GE, where he led GE’s Healthcare IT Service Business in the Americas, served as the GM of GE’s Enterprise Revenue Cycle Business and led business transformation activities for GE’s Chief Information Officer. Mike’s early career included five years with McKinsey & Company and six years as a U.S. Army Officer. He holds a Master of Business Administration degree from The University of Chicago Booth School of Business and a Bachelor’s Degree from the University of Notre Dame.

“Mike is the ideal leader for Bracket as we scale the business and broaden the company’s impact on clinical research,” said David Golde, Director at Genstar Capital. “With Mike’s deep background in healthcare, his successful track record as a technology executive and his pragmatic leadership style, I’m confident in his ability to accelerate Bracket’s growth initiatives, both organically and through acquisitions, as Bracket continues to increase the value proposition it provides to its customers. We are also very grateful for Jeff Kinell’s integral role in establishing Bracket as a market leader, and we are pleased that he will continue to be involved with Bracket as a strategic advisor to the company.”

About Bracket
Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Bracket Strengthens Global Growth and Development Strategy with New Chief Commercial Officer, Christopher Crucitti

WAYNE, Pa., — Bracket, a leading clinical trial technology and specialty services provider, today announced the addition of Christopher Crucitti, Chief Commercial Officer to its global executive team. Crucitti joins Bracket as an experienced commercial leader in clinical and R&D services.

Crucitti brings industry-recognized experience, knowledge and integrity to Bracket’s leadership team as well as notable accomplishments in training and motivating other commercial professionals to provide a high level of customer service and overall performance. He will be responsible for the global commercial strategy and development of Bracket’s electronic clinical outcomes assessments (eCOA) and patient engagement platform, Randomization and Trial Supply Management (RTSM), Rater Training and Quality Assurance as well the Company’s expanding mobile suite for patient diary and analytics, among others.

“It’s with great excitement that we welcome Chris to our leadership team,” said Jeff Kinell, CEO at Bracket. “Chris brings an impressive resume in clinical commercial strategy to Bracket and has joined us at a pivotal time, as we continue to position ourselves competitively in the global marketplace through the increased use of Bring Your Own Device mobile solutions for patient engagement. We look forward to the unique and seasoned perspective Chris will bring to our team and global commercial strategy.”

Prior to joining Bracket, Crucitti served as Chief Commercial Officer at Science Exchange, a world-leading marketplace for outsourced research and as Executive Vice President, Global Business Development at Worldwide Clinical Trials, Inc., a global CRO that provides full-service drug development services to the pharma and biotech industries. Crucitti also held senior roles at InVentiv Health Clinical and i3 Research, a pharmaceutical services company that provides integrated solutions throughout the product lifecycle.

“I’m extremely excited to join Bracket, with its many smart and committed team members, leveraging my experience in clinical development services and technology to further optimize our commercial growth strategy,” said Crucitti, Chief Commercial Officer at Bracket. “With recent and imminent expansion on the horizon, the ability to communicate how our suite of technologies and solutions empower patient engagement to ultimately improve outcomes will be paramount; I look forward to the challenge and the many opportunities to expedite the process of getting meaningful treatments in the hands of patients that need them.”

Crucitti earned his Masters of Science in Health Management from American University and his Bachelors of Science in Cardiac Rehabilitation and Exercise Science from Ithaca College.

About Bracket
Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.